Annual ROE
-118.05%
+189.85%+61.66%
December 1, 2024
Summary
- As of March 11, 2025, BBLG annual return on equity is -118.05%, with the most recent change of +189.85% (+61.66%) on December 1, 2024.
- During the last 3 years, BBLG annual ROE has fallen by -93.55% (-381.84%).
- BBLG annual ROE is now -138.15% below its all-time high of 309.42%, reached on December 31, 2016.
Performance
BBLG ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-118.68%
+6.01%+4.82%
December 1, 2024
Summary
- As of March 11, 2025, BBLG quarterly return on equity is -118.68%, with the most recent change of +6.01% (+4.82%) on December 1, 2024.
- Over the past year, BBLG quarterly ROE has stayed the same.
- BBLG quarterly ROE is now -123.97% below its all-time high of 495.16%, reached on June 30, 2016.
Performance
BBLG Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BBLG ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +61.7% | 0.0% |
3 y3 years | -381.8% | 0.0% |
5 y5 years | -509.0% | 0.0% |
BBLG ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -381.8% | +61.7% | -371.9% | +50.5% |
5 y | 5-year | -509.0% | +61.7% | -371.9% | +50.5% |
alltime | all time | -138.2% | +61.7% | -124.0% | +50.5% |
Bone Biologics ROE History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -118.05%(-61.7%) | -118.68%(-4.8%) |
Sep 2024 | - | -124.69%(-19.1%) |
Jun 2024 | - | -154.16%(+1.4%) |
Mar 2024 | - | -151.98%(-35.6%) |
Dec 2023 | -307.90%(+1133.6%) | -236.04%(+65.1%) |
Sep 2023 | - | -142.93%(+15.8%) |
Jun 2023 | - | -123.42%(+28.1%) |
Mar 2023 | - | -96.32%(+256.5%) |
Dec 2022 | -24.96%(+1.9%) | -27.02%(-40.3%) |
Sep 2022 | - | -45.23%(-81.1%) |
Jun 2022 | - | -239.93%(-649.8%) |
Mar 2022 | - | 43.64%(+152.5%) |
Dec 2021 | -24.50%(-283.8%) | 17.28%(+31.8%) |
Sep 2021 | - | 13.11%(+3.0%) |
Jun 2021 | - | 12.73%(+3.4%) |
Mar 2021 | - | 12.31%(-11.9%) |
Dec 2020 | 13.33% | 13.97%(-7.4%) |
Sep 2020 | - | 15.09%(-11.5%) |
Jun 2020 | - | 17.05%(-24.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | 22.46%(-27.7%) |
Dec 2019 | 28.86%(-44.0%) | 31.08%(-27.3%) |
Sep 2019 | - | 42.78%(-3.2%) |
Jun 2019 | - | 44.20%(-11.2%) |
Mar 2019 | - | 49.80%(-5.1%) |
Dec 2018 | 51.53%(-38.6%) | 52.49%(-23.1%) |
Sep 2018 | - | 68.29%(-19.0%) |
Jun 2018 | - | 84.35%(+43.8%) |
Mar 2018 | - | 58.64%(-21.4%) |
Dec 2017 | 83.99%(-72.9%) | 74.58%(-49.7%) |
Sep 2017 | - | 148.30%(-21.4%) |
Jun 2017 | - | 188.68%(-37.3%) |
Mar 2017 | - | 301.01%(-31.0%) |
Dec 2016 | 309.42%(+26.7%) | 436.00%(-4.9%) |
Sep 2016 | - | 458.35%(-7.4%) |
Jun 2016 | - | 495.16%(+12.0%) |
Mar 2016 | - | 442.01%(+81.0%) |
Dec 2015 | 244.26%(+104.2%) | 244.26% |
Dec 2014 | 119.63% | - |
FAQ
- What is Bone Biologics annual return on equity?
- What is the all time high annual ROE for Bone Biologics?
- What is Bone Biologics annual ROE year-on-year change?
- What is Bone Biologics quarterly return on equity?
- What is the all time high quarterly ROE for Bone Biologics?
- What is Bone Biologics quarterly ROE year-on-year change?
What is Bone Biologics annual return on equity?
The current annual ROE of BBLG is -118.05%
What is the all time high annual ROE for Bone Biologics?
Bone Biologics all-time high annual return on equity is 309.42%
What is Bone Biologics annual ROE year-on-year change?
Over the past year, BBLG annual return on equity has changed by +189.85% (+61.66%)
What is Bone Biologics quarterly return on equity?
The current quarterly ROE of BBLG is -118.68%
What is the all time high quarterly ROE for Bone Biologics?
Bone Biologics all-time high quarterly return on equity is 495.16%
What is Bone Biologics quarterly ROE year-on-year change?
Over the past year, BBLG quarterly return on equity has changed by 0.00% (0.00%)